Column GROUP Iii, L.P., 10% Owner, Director at NGM BIOPHARMACEUTICALS INC (NGM), bought 38,139 shares at $5.00 ($191K) on 2023-01-19, disclosed to the SEC on 2023-01-23.
Open-market purchase of $191k NGM by 10% Owner, Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.00 | 37,639 | $188K | 98.7% |
| 2 | $5.00 | 500 | $3K | 1.3% |
| Total | $5.00 avg | 38,139 | $191K | 100% |
| Filing → |
| TNYA | BUY | 2023-03-14 | $18K | — | Filing → |
| TNYA | BUY | 2022-11-23 | $50.0M | — | Filing → |
| NGM | BUY | 2020-08-25 | $661K | — | Filing → |